Elixir Medical Announces Outstanding Long-Term Clinical Results at EuroPCR for World’s Broadest Portfolio of Three CE ...

Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today excellent long-term results of its CE Mark-approved DESyne Novolimus Eluting Coronary Stent System and CE Mark-approved DESyne BD Novolimus Eluting Coronary Stent System with biodegradable polymer, both compared to the control Endeavor Zotarolimus ...



from Content Keyword RSS http://ift.tt/1n9sd3c

via IFTTT